Life Science Webinars
-
An Integrated Single-Use Platform for Manufacturing Plasmid DNA (pDNA)
4/3/2020
Plasmid DNA (pDNA) plays a critical role in the delivery of gene therapies into targeted cells. The development and delivery of large quantity, high-quality pDNA vectors are in high demand. Cytovance has developed and integrated Single-use Platform for manufacturing Plasmid DNA (pDNA) using the HyperGRO™ high cell density process that is licensed from Nature Technologies, an industry leader in the field.
-
High-Density Cell Banking Webinar
3/5/2020
Learn how high-density cell banking can shorten the seed training process from weeks to days! High-density cell banking accelerates the upstream process by providing a much larger volume of concentrated cells at the start of a production run. This innovative process eliminates many of the labor intensive and risky approaches currently used by most bioprocessing labs.
-
Expanding SPR Uses In Antibody Effector Function Determination
2/25/2020
SPR can be implemented at early stages in screening and testing strategies in order to provide better, faster, and stronger analysis of drug candidates. In order to minimize risk and to get “true” affinity in binding analysis, we have adopted the latest innovation in surface plasmon resonance (SPR) technology, Biacore™ 8K, to develop and qualify assays for monoclonal antibodies and other therapeutic proteins to ensure all critical quality attributes are set and controlled with accuracy and precision.
-
Novel Analytics To Improve Bioprocessing And Validation Guideline Review
2/25/2020
A thorough understanding of how the process impacts the product quality attributes is essential for decision-making. Implementation of a robust analytical control strategy with information-rich technologies has the potential to significantly improve characterization and productivity. This presentation will provide an overview of how innovative protein analysis tools have been adopted for better comparability, release testing, and impurity monitoring.
-
Insights in Pharmaceutical Manufacturing, Clinical Research and Technology
2/13/2020
ISR conducted approximately two dozen pieces of research for syndication in 2019. This summary highlights learnings from these projects, and provides real, usable data for 2020 activities.
-
Reduce Product Variability, Control Temp Rates To Improve Cell Therapies
2/4/2020
Reduced input variables and careful freeze/thaw cycles are critical in T cell processing. Here, experts examine how these factors influence and optimize mononuclear cell enrichment and cryopreservation.
-
Principles Of Immunogenicity Assessment Using Biacore T200 SPR System
2/4/2020
Usually, ligand binding technologies such as ELISA are used for early immune responses, whereas SPR technology is utilized for the characterization of antibody isotypes.
-
Process Characterization: Ready For The FDA? (Webinar)
1/31/2020
In this webinar, Greg Sears, Ph.D, Global Director, Process Characterization, Head of Manufacturing Science and Technology, Pharma Services, Biologics at Thermo Fisher Scientific, discusses process characterization basics, including information on what’s optional vs. what’s required.
-
Low-Temperature Solutions For Bioprocess Applications
12/26/2019
Janelle Rupkalvis, Life Sciences applications explains the importance of having a complete, cold-resistant solution of bags, tubing, connectors, and shells.
-
Advanced Analytical Tools For Drug Product Development
12/23/2019
Gain insight into analytical techniques that reveal answers during product development, with an emphasis on Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (MS).